Investigation on Polymorphs of Apixaban, an Anticoagulant Drug: Study of Phase Transformations and Designing Efficient Process for their Preparation

Authors

  • Pavankumar V. Solanki Department of Process Research and Development, Megafine Pharma (P) Ltd., 201, Lakhmapur, Dindori, Nashik-422 202, Maharashtra, India
  • Sekhar Babu Uppelli Department of Process Research and Development, Megafine Pharma (P) Ltd., 201, Lakhmapur, Dindori, Nashik-422 202, Maharashtra, India
  • Pramod A. Dhokrat Department of Process Research and Development, Megafine Pharma (P) Ltd., 201, Lakhmapur, Dindori, Nashik-422 202, Maharashtra, India
  • Saroj R. Bembalkar Department of Chemistry, Deogiri College, Aurangabad, 431004, India
  • Vijayavitthal T. Mathad Department of Process Research and Development, Megafine Pharma (P) Ltd., 201, Lakhmapur, Dindori, Nashik-422 202, Maharashtra, India

Keywords:

Apixaban, Atrial fibrillation; Coagulation factor Xa inhibitors Anticoagulant, Polymorph transformation

Abstract

The present work describes the investigation on the polymorphs of Apixaban (1), an anticoagulant drug obtained by following basic synthetic process known in the prior art. Polymorphs present inherently in the basic process are identified, synthesized and characterized. Robust and efficient process for the preparation of apixaban (1) and their different polymorphs has been described based on the understanding of solvent mediated phase transformations, solid-solid phase transformation and suitable medium in which phases are effectively formed. Process optimization details conducted towards the synthesis of identified polymorphs of apixaban with high chemical and polymorphic purity are presented.

Downloads

Published

2015-03-05

How to Cite

Pavankumar V. Solanki, Sekhar Babu Uppelli, Pramod A. Dhokrat, Saroj R. Bembalkar, & Vijayavitthal T. Mathad. (2015). Investigation on Polymorphs of Apixaban, an Anticoagulant Drug: Study of Phase Transformations and Designing Efficient Process for their Preparation. World Journal of Pharmaceutical Sciences, 3(3), 663–677. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/polymorphs-apixaban-anticoagulant-drug-phase-transformations

Issue

Section

Research Article